Press Release:
Researchers from Brain Research Institute, Niigata University, Japan may have unraveled a new approach that could revolutionize the treatment, prevention, and possibly reversal of the damages that could lead to Parkinson’s Disease (PD). This novel finding utilizing the cellular and zebrafish models, demonstrated how the leakage of mitochondrial dsDNA into the cytosol environment of the cell can contribute to the impairment of brain tissue of patients with PD.
Parkinson’s disease is the second most common neurodegenerative disease, and its prevalence has been projected to double over the next 30 years.
These sobering statistics and the quest for PD prognostic marker discovery inspired a team of scientists led by Prof. Hideaki Matsui to build upon previous knowledge that link mitochondrial dysfunction and lysosomal dysfunction to PD. In an interview Prof. Matsui said, “Our results showed for the first time that cytosolic dsDNA of mitochondrial origin leaking and escaping from lysosomal degradation can induce cytotoxicity both in cultured cells, as well as in zebrafish models of Parkinson’s disease.”
Prof. Matsui went on to explain that “This study showed that the leakage of this mitochondrial nucleic material may occur as a result of mitochondrial dysfunction, which may involve genetic mutations in genes encoding mitochondrial proteins or incomplete degradation of mitochondrial dsDNA in the lysosome – which is a “degradation factory” of the cell. Upon the leakage into the cytoplasm, this undegraded dsDNA is detected by a “foreign” DNA sensor of the cytoplasm (IFI16) which then triggers the upregulation of mRNAs encoding for inflammatory proteins (type I interferon stimulated cytokines such as IL1β). Although further investigation is required, we hypothesize that the subsequent accumulation of inflammatory protein within the cytoplasm, may cause cell functional imbalance and ultimately cell death.”
“However, this dsDNA leakage effect can be counteracted by DNAse II, a dsDNA degrading agent.”, Prof. Akiyoshi Kakita, who was an associate investigator in the study also added.
The first part of the study was conducted in vitro, using cells of nerve cancer origin (SH-SY5Y cells) with defective mitochondria and lysosomal dysfunctions through knockdown of GBA, ATP13A and PINK1 genes. The mutant cells demonstrated leakage of dsDNA and accumulation of inflammatory cytokines and cell death. In an additional comparison experiment using mutant cells (with defective mitochondrial proteins) and wild type SH-SY5Y cells, they further demonstrated that DNAse II rescued cells through the degradation of dsDNA.
In a confirmatory study using a PD zebrafish model (gba mutant), the researchers demonstrated that a combination of PD-like phenotypes including accumulation of cytosol dsDNA deposits, reduced number of dopaminergic neurons after 3 months. Lastly, they further generated a DNase II mutant zebrafish model which exhibited decreased numbers of dopaminergic neurons and demonstrated accumulated cytosolic DNA. Interestingly, when then gba mutant zebrafish was complemented with human DNAse II gene, the overexpression of human DNAse II decreased cytosolic dsDNA deposits, rescued neuro-degradation by rescuing the number of dopaminergic and noradrenergic neurons after 3 months.
This demonstrated that neurodegenerative phenotype of gba mutant zebrafish induced by dsDNA deposits in the cytosol can be restored by DNAse II.
In a step further, to determine the effect of cytosolic dsDNA of mitochondrial origin in human brain with Parkinson’s disease, they inspected postmortem human brain tissues from patients who were diagnosed with idiopathic PD. They observed abundance of cytosolic dsDNA of mitochondrial origin in medulla oblongata of postmortem brain tissues, the levels of IFI16 were also markedly increased in these brain tissues. Taken together, results in this study demonstrated that cytosolic dsDNA of mitochondrial origin accumulated in PD brains and that these dsDNA deposits and IFI16 play contributory roles in human PD pathogenesis.
Advertisement:
- Okun MD, Michael (Author)
- English (Publication Language)
- 320 Pages - 04/03/2020 (Publication Date) - Robert Rose (Publisher)
- LeWitt MD, Peter (Author)
- English (Publication Language)
- 126 Pages - 06/09/2020 (Publication Date) - Callisto (Publisher)
- Horne, Jo (Author)
- English (Publication Language)
- 448 Pages - 08/16/2022 (Publication Date) - For Dummies (Publisher)
- Meldrum, Kristine (Author)
- English (Publication Language)
- 223 Pages - 12/14/2023 (Publication Date) - Independently published (Publisher)
- Shifke, Howard (Author)
- English (Publication Language)
- 282 Pages - 11/16/2017 (Publication Date) - CreateSpace Independent Publishing Platform (Publisher)
- Dorsey MD, Ray (Author)
- English (Publication Language)
- 352 Pages - 03/16/2021 (Publication Date) - PublicAffairs (Publisher)
- Parkinson's Awareness Theme: wear these grey ribbon Parkinson's disease awareness wristbands raise awareness about Parkinson's disease, and encourage people to lead a healthy lifestyle
- What You Get: there are 100 pieces of Parkinson's awareness wristband in 10 styles, 10 pieces for each style, sufficient quantity and various styles for you to use and share, showing love and support for one you care
- Comfortable to Wear: made of quality silicone, these Parkinson's awareness wristband are bright in color, light in weight, comfortable to wear, and the circumference is about 7.95 inch, also stretchable, which fits the wrist size of most people
- Inspirational Sayings: these Parkinson's awareness rubber wristbands are imprinted with different inspirational sayings, such as "We Fight Together" "Never Stop Fighting" and more
- Widely Applied: these Parkinson's awareness wristbands can be as ideal gifts for various world Parkinson's day events, such as health awareness walks, which also make cheerful gifts for friends, family members, colleagues, or any loved ones in your life
- HAMILTON, DAVID (Author)
- English (Publication Language)
- 111 Pages - 01/05/2025 (Publication Date) - Independently published (Publisher)
- Hardcover Book
- Ahlskog PhD MD, J. Eric (Author)
- English (Publication Language)
- 544 Pages - 09/01/2015 (Publication Date) - Oxford University Press (Publisher)
- Used Book in Good Condition
- Peterman Schwarz, Shelley (Author)
- English (Publication Language)
- 140 Pages - 06/06/2006 (Publication Date) - Demos Health (Publisher)
I get commissions for purchases made through links on this website. As an Amazon Associate I earn from qualifying purchases.